RETRACTION: Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway (Retraction of Vol 12, art no 1758835920965853, 2020)

被引：0
|
作者：
Tong, F.
Xiong, C.
Wei, C.
机构：
来源：
THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY | 2023年 / 15卷
关键词：
D O I：
10.1177/17588359231165586
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Hypofractionated Radiotherapy Normalizes Tumor Vasculature in Non-Small Cell Lung Cancer Xenografts Through p-STAT3/HIF-1 Alpha Pathway
    Jin, X.
    Tong, F.
    Dong, X.
    Wei, C.
    Lu, H.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S455 - S455
  • [2] RETRACTED: Hypo-fractionation radiotherapy normalizes tumor vasculature in non-small cell lung cancer xenografts through the p-STAT3/HIF-1 alpha signaling pathway (Retracted article. See vol. 15, 2023)
    Tong, Fan
    Xiong, Chun-jin
    Wei, Chun-hua
    Wang, Ye
    Liang, Zhi-wen
    Lu, Hui
    Pan, Hui-jiao
    Dong, Ji-hua
    Zheng, Xue-feng
    Wu, Gang
    Dong, Xiao-rong
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
  • [3] RETRACTION: MicroRNA-330-3p promotes cell invasion and metastasis in non-small cell lung cancer through GRIA3 by activating MAPK/ERK signaling pathway (Retraction of Vol 10, art no 125, 2017)
    Wei, Chun-Hua
    Wu, Gang
    Cai, Qian
    Gao, Xi-Can
    Tong, Fan
    Zhou, Rui
    Zhang, Rui-Guang
    Dong, Ji-Hua
    Hu, Yu
    Dong, Xiao- Rong
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2020, 13 (01)
  • [4] RETRACTION: IKBKE is induced by STAT3 and tobacco carcinogen and determines chemosensitivity in non-small cell lung cancer (Retraction of Vol 32, art no 151, 2012)
    Guo, J.
    Kim, D.
    Gao, J.
    Kurtyka, C.
    Chen, H.
    Yu, C.
    Wu, D.
    Mittal, A.
    Beg, A. A.
    Chellappan, S. P.
    Haura, E. B.
    Cheng, J. Q.
    ONCOGENE, 2024, 43 (16) : 1231 - 1231
  • [5] RETRACTION: miR-202 functions as a tumor suppressor in non-small cell lung cancer by targeting STAT3 (Retraction of Vol 16, Pg 2281, 2017)
    Zhao, Zhonghai
    Lv, Bin
    Zhang, Li
    Zhao, Nana
    Lv, Yan
    MOLECULAR MEDICINE REPORTS, 2022, 26 (04)
  • [6] RETRACTION: Chrysophanol exhibits anti-cancer activities in lung cancer cell through regulating ROS/HIF-1a/VEGF signaling pathway (Retraction of Vol 393, Pg 469, 2020)
    Zhang, Jie
    Wang, Qian
    Wang, Qiang
    Guo, Peng
    Wang, Yong
    Xing, Yuqing
    Zhang, Mengmeng
    Liu, Fujun
    Zeng, Qingyun
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2021, 394 (03) : 577 - 578
  • [7] RETRACTION: KDM4A promotes the growth of non-small cell lung cancer by mediating the expression of Myc via DLX5 through the Wnt/β-catenin signaling pathway (Retraction of Vol 262, art no 118508, 2020)
    Sun, Shanshan
    Yang, Fujun
    Zhu, Yongcun
    Zhang, Shukun
    LIFE SCIENCES, 2022, 306
  • [8] Downregulation of Rab17 promotes cell proliferation and invasion in non-small cell lung cancer through STAT3/HIF-1α/VEGF signaling
    Wang, Mingliang
    Wang, Wendong
    Ding, Jingmin
    Wang, Jiashun
    Zhang, Jun
    THORACIC CANCER, 2020, 11 (02) : 379 - 388
  • [9] RETRACTION: CSF-1R regulates non-small cell lung cancer cells dissemination through Wnt3a signaling (Retraction of Vol 7, Pg 2144, 2017)
    Yu, Y. X.
    Wu, H. J.
    Tan, B. X.
    Qiu, C.
    Liu, H. Z.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2019, 9 (02): : 458 - 458
  • [10] RETRACTION: GBP1 promotes non-small cell lung carcinoma malignancy and chemoresistance via activating the Wnt/β-catenin signaling pathway (Retraction of Vol 24, Pg 5465, 2020)
    Song, J.
    Wei, O. -Y.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (13) : 7221 - 7221
12345